Publications:

MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research

Yip, Stephen S; Miao, Jiangyong J; Cahill, Daniel P DP; Iafrate, A John AJ; Aldape, Ken K; Nutt, Catherine L CL; Louis, David N DN

Publication Date: 2009-07-15

Variant appearance in text: MSH6: Val809X

PubMed Link: 19584161

Variant Present in the following documents:

• Main text

View BVdb publication page

Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research

Cahill, Daniel P DP; Levine, Kymberly K KK; Betensky, Rebecca A RA; Codd, Patrick J PJ; Romany, Candice A CA; Reavie, Linsey B LB; Batchelor, Tracy T TT; Futreal, P Andrew PA; Stratton, Michael R MR; Curry, William T WT; Iafrate, A John AJ; Louis, David N DN

Publication Date: 2007-04-01

Variant appearance in text: MSH6: V809X

PubMed Link: 17404084

Variant Present in the following documents:

• Main text

View BVdb publication page